Skip to main content

Substantial Equivalence Explained

Substantial equivalence (SE) is the standard a 510(k) submission must meet. It is the core legal concept of the 510(k) pathway.


The statutory standardโ€‹

Under FD&C Act ยง 513(i), a device is substantially equivalent to a predicate if it:

  1. Has the same intended use as the predicate; and
  2. Has the same technological characteristics as the predicate; OR
    • Has different technological characteristics that do not raise different questions of safety and effectiveness; and
    • The information in the submission demonstrates that the device is at least as safe and effective as the legally marketed device.

Intended use comparisonโ€‹

Same intended use: The new device and the predicate must have the same general intended use โ€” they don't need to have identical intended uses, but the new device's intended use must fall within the same general category.

Different intended use: If the new device has a different intended use from the predicate, the device is not substantially equivalent โ€” regardless of how similar the technology is.


Technological characteristics comparisonโ€‹

If intended use is the same, FDA then evaluates technological characteristics:

Same technological characteristics: FDA typically finds SE with limited additional data.

Different technological characteristics: FDA evaluates whether the differences:

  1. Raise new questions of safety and effectiveness โ€” if yes, NSE is likely
  2. If no new questions are raised, FDA evaluates whether the device is at least as safe and effective as the predicate, typically through:
    • Bench testing (performance data)
    • Biocompatibility data (ISO 10993)
    • Software documentation
    • Sterility/packaging validation
    • Clinical data (if non-clinical data is insufficient)

The SE decision treeโ€‹

New device
โ”‚
โ–ผ
Same intended use as predicate?
โ”‚
โ”œโ”€โ”€ No โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€ โ†’ NSE
โ”‚
โ””โ”€โ”€ Yes
โ”‚
โ–ผ
Same technological characteristics?
โ”‚
โ”œโ”€โ”€ Yes โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€ โ†’ SE (with appropriate data)
โ”‚
โ””โ”€โ”€ No
โ”‚
โ–ผ
Do differences raise new safety/effectiveness questions?
โ”‚
โ”œโ”€โ”€ Yes โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€ โ†’ NSE (likely)
โ”‚
โ””โ”€โ”€ No
โ”‚
โ–ผ
Data demonstrates at least as safe/effective as predicate?
โ”‚
โ”œโ”€โ”€ Yes โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€ โ†’ SE
โ””โ”€โ”€ No โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€ โ†’ NSE

What SE is notโ€‹

Substantial equivalence does not mean:

  • The device is identical to the predicate
  • The device is as good as the predicate in every way
  • The device meets an absolute safety/effectiveness threshold

It is a comparative standard โ€” the device must be at least as safe and effective as the predicate.


Official resourcesโ€‹